Verapamil Hydrochloride NDC 71335-2087

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2087Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2087Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71335-2087-1	71335208701	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71335-2087-1)Marketed from May 16, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Verapamil Hydrochloride
Generic name (nonproprietary): verapamil hydrochloride
Active ingredients: Verapamil hydrochloride — 40 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 072924
Marketing start: Jun 29, 1993
Listing expires: Dec 31, 2026
Other FDA classes: Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 71335-2087_aa812d96-3c8c-4cdf-b31d-5674cfa5c8c5SPL ID aa812d96-3c8c-4cdf-b31d-5674cfa5c8c5SPL set ID 2f232216-db62-4dc6-a5a7-9139d7ac7589RxCUI 897722UNII V3888OEY5R
Pharmacologic class: Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335208701 followed by a unit qualifier and the quantity

Package 71335-2087-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 24, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Verapamil Hydrochloride Tablets are indicated for the treatment of the following: Angina 1. Angina at rest including: – Vasospastic (Prinzmetal’s variant) angina – Unstable (crescendo, pre-infarction) angina 2. Chronic stable angina (classic effort-associated angina) Arrhythmias 1. In association with digitalis for the control of ventricular rate at rest and during stress in patients with chronic atrial flutter and/or atrial fibrillation (see WARNINGS; Accessory bypass tract ) 2. Prophylaxis of repetitive paroxysmal supraventricular tachycardia Essential hypertension: Verapamil is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood press…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 072924

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 072924
Product	Strength	Form · route	Labeler	Product NDC
Verapamil Hydrochloride	Verapamil hydrochloride 40 mg/1	Tablet, Film coatedOral	Actavis Pharma, Inc.	0591-0404